Wounds destroy healthy skin and mucous membranes that appear in multiple ways such as brass, laceration, puncture and avulsion. Wounds can be permanent or acute. Acute wounds are caused by injuries and are sustained by surgery. In comparison, chronic injuries are associated with significant systemic diseases such as pneumonia, dental ulceration, stomatitis and slow wound healing and usually do not heal adequately and rapidly.
Access Full Report at https://www.databridgemarketresearch.com/reports/global-advanced-wound-care-market
Data Bridge Market Research analyses that the Advanced Wound Care Market was valued at USD 9.4 billion in 2021 and is expected to reach USD 15.91 billion by 2029, registering a CAGR of 6.80% during the forecast period of 2022 to 2029. The demand for advanced wound care will increase further due to the sharp increase in hospital visits for wound treatment. Growing healthcare spending to provide better patient care and a significant number of therapeutic operations carried out in hospitals will boost the expansion of the hospital industry. Furthermore, the prevalence of pressure ulcers developed in hospitals is rising, increasing the need for better wound care and raising the industry's worth.
The increasing prevalence of chronic diseases and conditions that affect the wound healing capacities across the world will drive the market's growth rate
Over the past ten years, there has been an increase in the prevalence of acute, chronic, and surgical wounds due to factors including an expanding global elderly population, rising traumatic wounds, an increase in surgeries, and an increase in the incidence of diseases including obesity and diabetes. Diabetes and obesity can significantly increase the frequency and complexity of wounds, including infections, ulcerations (such as leg or foot ulcers), and chronic wounds. These wounds all require therapy (advanced wound management), which raises the expense of healthcare.
Report Scope and Market Segmentation
Report Metric
|
Details
|
Forecast Period
|
2022 to 2029
|
Base Year
|
2021
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
Segments Covered
|
Product Type (Dressing, Therapy Device, Biologics, Others), Wound Type (Primary Wound Care, Secondary Wound Care), Wound Class (Class I, Class II, Class III, Class IV), End User (Hospitals, Wound Care Centres, Ambulatory Centres, Home Healthcare, Clinics, Others), Distribution Channel (Direct Tenders, Retail)
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
Market Players Covered
|
3M (U.S.), Smith+Nephew (U.K.), ConvaTec Group Plc (U.K.), Coloplast Group (Denmark), Mölnlycke Health Care AB (Sweden), Integra LifeSciences (U.S.), PAUL HARTMANN (Germany), B. Braun Melsungen AG (Germany), Cardinal Health, Inc. (U.S.), Organogenesis Inc. (U.S.), Misonix, Inc. (U.S.), MIMEDX (U.S.), Zimmer Biomet (U.S.), Lohmann & Rauscher GmbH & Co. KG (Germany), DeRoyal Industries, Inc. (U.S.), Medline Industries, Inc. (U.S.), Johnson & Johnson Private Limited (U.S.), Baxter (U.S.), Medtronic (Ireland), Hollister Incorporated (U.S.) among others
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis:
Global advanced wound care market is segmented into five notable segments which are on the basis of the product type, wound type, wound class, end user and distribution channel.
- On the basis of product type, the advanced wound care market is classified into dressing, biologics, therapy devices and others. In 2021, dressing segment is expected to dominate the advanced wound care market with 44.6% market share because it is considered to be the first step in wound treatment as well as plays an important role in wound management.
- On the basis of wound type, the global advanced wound care market is classified into primary wound care and secondary wound care. In 2021, primary wound care segment is expected to dominate the market with 69.6% market share because it is considered to be the first step in wound treatment as well as plays an important role in wound management. After primary wound care, secondary wound care type is done to cover the wound.
- On the basis of end user, the global advanced wound care market is classified into hospitals, wound care centers, ambulatory centers, home healthcare, clinics and others. In 2021, hospitals segment is expected to dominate the market with 44.1% market share as higher number of patients prefer to visit hospitals for different cases such as surgical wound, burns, ulcers and others. However, wound care centers segment is growing with the highest growth rate because of the availability of better facility and treatment of patients for wounds.
醫院部門將主導先進傷口護理市場的最終用戶部分
醫院部門將成為主導的最終使用者部門。這是因為市場上的診所數量不斷增加，尤其是在發展中經濟體。此外，全球範圍內研究開發服務的成長和擴張將進一步促進該領域的成長。
- 根據分銷管道，全球先進傷口護理市場分為直接招標和零售。 2021 年，直接招標領域預計將佔據市場主導地位，市場份額為 78.8%，因為大多數與高級傷口護理相關的產品直接分發到醫院、傷口護理中心等各個地方。
直接投標部分將主導先進傷口護理 市場的分銷管道部分
直接投標部分將成為分銷管道的主導部分。這是因為市場上尤其是發展中經濟體的基礎設施開發活動不斷增加。此外，全球醫療保健產業的成長和擴張將進一步促進該領域的成長。
主要參與者
Data Bridge Market Research 將以下公司視為市場參與者：3M（美國）、Smith+Nephew（英國）、ConvaTec Group Plc（英國）、Coloplast Group（丹麥）、Mölnlycke Health Care AB（瑞典）、Integra LifeSciences（美國）、PAUL HARTMANN（德國）、B. Braun Melsungen AG（德國） Inc.（美國）、Misonix, Inc.（美國）、MIMEDX（美國）、Zimmer Biomet（美國）、Lohmann & Rauscher GmbH & Co. KG（德國）、DeRoyal Industries, Inc.（美國）、Medline Industries, Inc.（美國）、Johnson & Johnson Private Limited（美國）、Btronax Limited（美國）。
市場開發
- 2019 年，AxioBiosolutions 在新德里舉行的 Endovascular Live 2019 上推出了 MaxioCel，這是一種基於殼聚醣的下一代傷口敷料，具有疼痛管理和疤痕改善的功效。本產品可用於治療糖尿病足潰瘍、靜脈潰瘍、腔內傷口、皮膚擦傷、供皮區及術後手術傷口等各類慢性傷口及其他各類複雜慢性傷口。這將有助於在更短的時間內治癒傷口。
- 2019年6月，史密斯+侄子（Smith+Nephew）推出了PICO 14一次性使用負壓傷口治療系統（sNPWT），其泵壓持續時間為2週，可用於深度7厘米的深傷口，無需任何用戶幹預。與傳統系統相比，這減少了對填充物的要求並降低了敷料的頻率。本產品採用 AIRLOC 技術，可在傷口和受傷周圍區域均勻可靠地輸送治療性 NPWT。
- 2018年5月，康樂保集團推出了採用3DFit技術的Biatain矽膠敷料。 Biatain Silicone 提供全面的泡棉敷料，為治療傷害或預防壓傷提供彈性。該產品有多種尺寸可供選擇。
區域分析
從地理上看，市場報告涵蓋的國家有：北美洲的美國、加拿大和墨西哥、歐洲的德國、法國、英國、荷蘭、瑞士、比利時、俄羅斯、義大利、西班牙、土耳其、歐洲其他地區、中國、日本、印度、韓國、新加坡、馬來西亞、澳洲、泰國、印尼、菲律賓、亞太地區（APAC）的其他地區、沙烏地阿拉伯、阿聯酋、南非、澳洲、其他國家的歐洲、歐洲、歐洲地區和其他國家的歐洲地區（歐洲地區的歐洲國家。
根據 Data Bridge 市場研究分析：
2022 年至 2029 年預測期內，北美是先進傷口護理市場的主導地區
由於北美越來越多地採用先進技術並推出新產品，北美在先進傷口護理市場佔據主導地位。此外，慢性傷口病例的增加和老年人口的增加將進一步提高該地區市場的成長率。
預計2022 年至 2029 年預測期內，亞太地區將成為先進傷口護理市場成長最快的地區
由於亞太地區存在主要市場參與者，預計預測期內該地區將實現成長。此外，醫療保健支出水準的提高將推動該地區市場的成長速度。
新冠肺炎疫情的影響
自 2019 年 12 月發現 COVID-19 病毒以來，該病毒已在全球範圍內傳播，世界衛生組織 (WHO) 已宣布該病毒為突發公共衛生事件。自從許多國家採取封鎖措施阻止 COVID-19 在社區內傳播以來，該病毒對該行業的負面影響已引起人們的關注。由於供應鏈中斷和非緊急面對面診所預約的減少，市場面臨短期中斷並產生了負面影響。由於新冠病毒疫情的迅速蔓延，一些製造商被迫停止生產和製造活動。人們在醫院和其他醫療機構中感染 COVID-19 的可能性抑制了市場的成長。
有關高級傷口護理市場的更多詳細信息，請訪問： https://www.databridgemarketresearch.com/reports/global-advanced-wound-care-market
